HOME › DRUGS › CLOFARABINE
ACTIVE SUBSTANCE / INN

CLOFARABINE

Brand name(s): Ivozall, Evoltra, CLOFARABINE, CLOLAR
FDA LISTED
EMA LISTED
DISCONTINUED
PRESCRIPTION
WITHDRAWN
ANDA210283
ANDA208167
ACTIVE SUBSTANCE
Clofarabine
REGULATORS
FDA · EMA
SPONSORS / MAH
HOSPIRA, ZYDUS PHARMS USA INC, GENZYME
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CLOFARABINEANDA208167ZYDUS PHARMS USA INCNone (Tentative Approval)
CLOFARABINEANDA209775MSNPrescription
CLOLARNDA021673GENZYMEDiscontinued
CLOFARABINEANDA210283HOSPIRADiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EvoltraSanofi B.V.Authorised29/05/2006Precursor Cell Lymphoblastic Leukemia-Lymphoma
IvozallORPHELIA PharmaWithdrawn14/11/2019Precursor Cell Lymphoblastic Leukemia-Lymphoma

FULL INTELLIGENCE ON CLOFARABINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →